John Hiemenz, M.D.

John W Hiemenz, M.D.

(352) 733-0972

Request an Appointment


Dietary intake and Diet Quality of Hematopoietic Stem Cell Transplant Survivors
Biology of Blood and Marrow Transplantation

Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients
Hematology/oncology and stem cell therapy (Print)

Anti-human cytomegalovirus monoclonal antibodies for prophylaxis in hematopoietic cell transplantation: a phase 2 study
Antimicrobial Agents and Chemotherapy

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients
Blood Advances

Poor Peripheral Blood Stem Cell Mobilization Affects Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Journal of Clinical Apheresis

Effect of Melphalan 140 Mg/M(2) Vs 200 Mg/M(2) on Toxicities and Outcomes in Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Transplantation-a Single Center Experience
Clinical Transplantation

A New Model to Predict Remission Status in Aml Patients Based on Day 14 Bone Marrow Biopsy
Leukemia Research

Poor Peripheral Blood Stem Cell Mobilization Correlates With Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Biology of Blood and Marrow Transplantation

A Cyp2C19 Genotype Guided Dosing Approach for Optimizing Voriconazole in Patients With Ifis.

Association of Mannose Binding Lectin (Mbl) Levels and Invasive Fungal Disease (Ifd) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (Hsct) Or Receiving Chemotherapy
Biology of Blood and Marrow Transplantation

Peripheral Blood Cd34(+) Specific Donor Chimerism Analysis as An Early Indicator of Disease Relapse After Allogeneic Hematopoietic Stem Cell Transplant in Patients With Myelodysplastic Syndromes and Acute Myelogenous Leukemia.

How I Manage Pulmonary Nodular Lesions and Nodular Infiltrates in Patients With Hematologic Malignancies Or Undergoing Hematopoietic Cell Transplantation

A Phase I Study of the Vascular Disrupting Combretastatin, Oxi4503, in Patients With Relapsed and Refractory Acute Myeloid Leukemia (Aml) and Myelodysplastic Syndromes (Mds)

Hematopoietic Stem Cell Transplantation: An Overview of Infection Risks and Epidemiology
Hematology/Oncology Clinics of North America

Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.
Infectious Disease Clinics of North America

Efficacy of Caspofungin as Salvage Therapy for Invasive Aspergillosis Compared To Standard Therapy in a Historical Cohort
Journal of Nursing Scholarship

Management of Infections Complicating Allogeneic Hematopoietic Stem Cell Transplantation
Seminars in Hematology

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis.


Research Interests

  • Dr. Hiemenz' academic interests include the diagnosis and treatment of hematological malignancies and primary bone marrow disorders, the use of hematopoietic stem cell transplantation for the treatment of malignant and non-malignant diseases, and supportive care for the patient undergoing intensive induction therapy and/or hematopoietic stem cell transplantation with particular interest in the diagnosis and management of graft versus host disease and infectious complications in the immune compromised host.

Active Research Studies